CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo.

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Abdullah Alajati; D'ambrosio Mariantonietta; Martina Troiani; Simone Mosole; Laura Pellegrini; Jingjing Chen; Ajinkya Revandkar; Marco Bolis; Jean-Philippe Theurillat; Ilaria Guccini; Marco Losa; Arianna Calcinotto; Gaston De Bernardis; Emiliano Pasquini; Rocco D'Antuono; Adam Sharp; Ines Figueiredo; Daniel Nava Rodrigues; Jonathan C. Welti; Veronica Gil; Wei Yuan; Tatjana Vlajnic; Lukas Bubendorf

Journal title: Journal of Clinical Investigation 130(5) 2435-2450

Journal number: 1

Journal publisher: American Society for Clinical Investigation

Published year: 2020

DOI identifier: 10.3929/ethz-b-000409240

ISSN: 0021-9738